Literature DB >> 30628670

Histone deacetylase 7 inhibits plakoglobin expression to promote lung cancer cell growth and metastasis.

Yi Sang1, Longhua Sun2, Yuanzhong Wu3, Wenxin Yuan4, Yanyan Liu5, Si-Wei Li6.   

Abstract

Plakoglobin is a tumor suppressor gene in lung cancer; however, the mechanism by which it is downregulated in lung cancer is largely unknown. The aim of the present study was to investigate whether histone deacetylases (HDACs) regulate plakoglobin expression in lung cancer. The effects of overexpression or knockdown of HDAC7 on plakoglobin were determined using stably transfected lung cancer cell lines. Chromatin immunoprecipitation assays were performed to elucidate the mechanisms underlying the HDAC7‑induced suppression of plakoglobin. A Cell Counting Kit‑8 and Transwell assays were performed, and a nude mouse in vivo model was established to investigate the role of the HDAC7/plakoglobin pathway in cell migration, invasion and metastasis. Ectopic expression of HDAC7 was identified to suppress mRNA and protein levels of plakoglobin in lung cancer cells, whereas silencing HDAC7 with short hairpin RNA increased the expression of plakoglobin. HDAC7 was proposed to suppressed plakoglobin by directly binding to its promoter. Overexpression or knockdown of HDAC7 promoted or inhibited cell proliferation, migration and invasion, respectively. Furthermore, knockdown of HDAC7 significantly suppressed tumor growth and metastasis in vivo. In addition, overexpression of plakoglobin significantly reduced the enhanced cell proliferation, migration and invasion induced by ectopic HDAC7. In conclusion, suppression of plakoglobin by HDAC7 promoted the proliferation, migration, invasion and metastasis in lung cancer. This novel axis of HDAC7/plakoglobin may be valuable in the development of novel therapeutic strategies for treating patients with lung cancer.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30628670     DOI: 10.3892/ijo.2019.4682

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  8 in total

Review 1.  Targeting Histone Deacetylases in Idiopathic Pulmonary Fibrosis: A Future Therapeutic Option.

Authors:  Martina Korfei; Poornima Mahavadi; Andreas Guenther
Journal:  Cells       Date:  2022-05-12       Impact factor: 7.666

2.  TRIM11 facilitates chemoresistance in nasopharyngeal carcinoma by activating the β-catenin/ABCC9 axis via p62-selective autophagic degradation of Daple.

Authors:  Runa Zhang; Si-Wei Li; Lijuan Liu; Jun Yang; Guofu Huang; Yi Sang
Journal:  Oncogenesis       Date:  2020-05-07       Impact factor: 7.485

3.  HDAC4 promotes nasopharyngeal carcinoma progression and serves as a therapeutic target.

Authors:  Chun Cheng; Jun Yang; Si-Wei Li; Guofu Huang; Chenxi Li; Wei-Ping Min; Yi Sang
Journal:  Cell Death Dis       Date:  2021-02-01       Impact factor: 8.469

4.  ZNF92, an unexplored transcription factor with remarkably distinct breast cancer over-expression associated with prognosis and cell-of-origin.

Authors:  Mohammad Kamran; Udayan Bhattacharya; Mohamed Omar; Luigi Marchionni; Tan A Ince
Journal:  NPJ Breast Cancer       Date:  2022-08-29

5.  THAP7 promotes cell proliferation by regulating the G1/S phase transition via epigenetically silencing p21 in lung adenocarcinoma.

Authors:  Cai-Ping Chen; Yi Sang; Lijuan Liu; Zhi-Qi Feng; Zibin Liang; Xiaofeng Pei
Journal:  Onco Targets Ther       Date:  2019-07-12       Impact factor: 4.147

6.  MiR-489 inhibited the development of gastric cancer via regulating HDAC7 and PI3K/AKT pathway.

Authors:  Haiyan Zhang; Lingyun Li; Cuicui Yuan; Congcong Wang; Tiantian Gao; Zhiwei Zheng
Journal:  World J Surg Oncol       Date:  2020-04-13       Impact factor: 2.754

7.  HDAC7 promotes the oncogenicity of nasopharyngeal carcinoma cells by miR-4465-EphA2 signaling axis.

Authors:  Qi-Guang Li; Ta Xiao; Wei Zhu; Zheng-Zheng Yu; Xiao-Pu Huang; Hong Yi; Shan-Shan Lu; Yao-Yun Tang; Wei Huang; Zhi-Qiang Xiao
Journal:  Cell Death Dis       Date:  2020-05-06       Impact factor: 8.469

8.  HDAC7 promotes NSCLC proliferation and metastasis via stabilization by deubiquitinase USP10 and activation of β-catenin-FGF18 pathway.

Authors:  Kai Guo; Zhiqiang Ma; Yujiao Zhang; Lu Han; Changjian Shao; Yingtong Feng; Fei Gao; Shouyin Di; Zhipei Zhang; Jiao Zhang; Fabrizio Tabbò; Simon Ekman; Kenichi Suda; Federico Cappuzzo; Jing Han; Xiaofei Li; Xiaolong Yan
Journal:  J Exp Clin Cancer Res       Date:  2022-03-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.